DRUG: Fitusiran sodium Help Entry D11810                      Drug                                    Name Fitusiran sodium (JAN); Qfitlia (TN) Product QFITLIA (Genzyme Corporation) Formula C520H636F21N175O309P43S6.43Na Exact mass 17185.1740 Mol weight 17193.40 Remark ATC code:  B02BX12 Product:  D11810<US> Efficacy Anthithrombin production inhibitor   Disease Hemophilia A or B [DS:H00219]   Type RNA interference (RNAi) drug Target SERPINC1 (AT3) [HSA:462] [KO:K03911]   Pathway hsa04610   Complement and coagulation cascades Brite Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]  B BLOOD AND BLOOD FORMING ORGANS   B02 ANTIHEMORRHAGICS    B02B VITAMIN K AND OTHER HEMOSTATICS     B02BX Other systemic hemostatics      B02BX12 Fitusiran       D11810  Fitusiran sodium (JAN) <US> Target-based classification of drugs [BR:br08310]  Peptidases and inhibitors   Peptidase inhibitors    Serpin family     SERPINC1 (AT3)      D11810  Fitusiran sodium (JAN) <US> New drug approvals in the USA [br08319.html]  New molecular entities and new therapeutic biological products   D11810 New drug approvals in the USA, Europe and Japan [br08328.html]  Approval dates by FDA, EMA and PMDA   D11810 BRITE hierarchy Other DBs PubChem:  405226675 LinkDB All DBs » Japanese version   » Back

DBGET integrated database retrieval system